16597666

Source:http://linkedlifedata.com/resource/pubmed/id/16597666

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0031740, umls-concept:C0031928, umls-concept:C0036043, umls-concept:C0178602, umls-concept:C0205191, umls-concept:C0387288, umls-concept:C0730328, umls-concept:C1515273, umls-concept:C1705313, umls-concept:C2349975, umls-concept:C2825407
pubmed:issue	7
pubmed:dateCreated	2006-6-19
pubmed:abstractText	To evaluate short term safety of an enhanced photodynamic therapy (PDT) protocol with half dose verteporfin for treating chronic central serous chorioretinopathy (CSC).
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/16597666-11884873, http://linkedlifedata.com/resource/pubmed/commentcorrection/16597666-12036670, http://linkedlifedata.com/resource/pubmed/commentcorrection/16597666-12049594, http://linkedlifedata.com/resource/pubmed/commentcorrection/16597666-12271373, http://linkedlifedata.com/resource/pubmed/commentcorrection/16597666-12678274, http://linkedlifedata.com/resource/pubmed/commentcorrection/16597666-12707605, http://linkedlifedata.com/resource/pubmed/commentcorrection/16597666-12824827, http://linkedlifedata.com/resource/pubmed/commentcorrection/16597666-14516825, http://linkedlifedata.com/resource/pubmed/commentcorrection/16597666-14660450, http://linkedlifedata.com/resource/pubmed/commentcorrection/16597666-14707823, http://linkedlifedata.com/resource/pubmed/commentcorrection/16597666-15078661, http://linkedlifedata.com/resource/pubmed/commentcorrection/16597666-15126146, http://linkedlifedata.com/resource/pubmed/commentcorrection/16597666-15183792, http://linkedlifedata.com/resource/pubmed/commentcorrection/16597666-15824216, http://linkedlifedata.com/resource/pubmed/commentcorrection/16597666-16384988, http://linkedlifedata.com/resource/pubmed/commentcorrection/16597666-16782941, http://linkedlifedata.com/resource/pubmed/commentcorrection/16597666-6521993, http://linkedlifedata.com/resource/pubmed/commentcorrection/16597666-7973118, http://linkedlifedata.com/resource/pubmed/commentcorrection/16597666-8053819, http://linkedlifedata.com/resource/pubmed/commentcorrection/16597666-8554078, http://linkedlifedata.com/resource/pubmed/commentcorrection/16597666-9068937
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0421041
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Photosensitizing Agents, http://linkedlifedata.com/resource/pubmed/chemical/Porphyrins, http://linkedlifedata.com/resource/pubmed/chemical/verteporfin
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0007-1161
pubmed:author	pubmed-author:ChanW-MWM, pubmed-author:LaiR Y KRY, pubmed-author:LaiT Y YTY, pubmed-author:LamD S CDS, pubmed-author:LiHH, pubmed-author:LiuD T LDT
pubmed:issnType	Print
pubmed:volume	90
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	869-74
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:16597666-Adult, pubmed-meshheading:16597666-Choroid Diseases, pubmed-meshheading:16597666-Chronic Disease, pubmed-meshheading:16597666-Drug Administration Schedule, pubmed-meshheading:16597666-Electroretinography, pubmed-meshheading:16597666-Female, pubmed-meshheading:16597666-Fluorescein Angiography, pubmed-meshheading:16597666-Humans, pubmed-meshheading:16597666-Male, pubmed-meshheading:16597666-Middle Aged, pubmed-meshheading:16597666-Photochemotherapy, pubmed-meshheading:16597666-Photosensitizing Agents, pubmed-meshheading:16597666-Pilot Projects, pubmed-meshheading:16597666-Porphyrins, pubmed-meshheading:16597666-Prospective Studies, pubmed-meshheading:16597666-Retina, pubmed-meshheading:16597666-Retinal Detachment, pubmed-meshheading:16597666-Tomography, Optical Coherence, pubmed-meshheading:16597666-Visual Acuity
pubmed:year	2006
pubmed:articleTitle	Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study.
pubmed:affiliation	Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Eye Hospital, Hong Kong.
pubmed:publicationType	Journal Article